Anti-Infectives
The global Anti-Infectives market was valued at 2270.73 Million USD in 2021 and will grow with a CAGR of 2.31% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors
Astra Zeneca plc
Johnson & Johnson
Glaxo SmithKline plc
Novartis
Pfizer
Wockhardt ltd
Roche
Sanofi
Merck
By Types
Antibacterial
Antiviral
Antifungal
By Applications
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Infectives Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-Infectives Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Antibacterial
1.4.3 Antiviral
1.4.4 Antifungal
1.5 Market by Application
1.5.1 Global Anti-Infectives Market Share by Application: 2022-2027
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Anti-Infectives Market
1.8.1 Global Anti-Infectives Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Anti-Infectives Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Infectives Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Infectives Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Infectives Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Anti-Infectives Sales Volume Market Share by Region (2016-2021)
3.2 Global Anti-Infectives Sales Revenue Market Share by Region (2016-2021)
3.3 North America Anti-Infectives Sales Volume
3.3.1 North America Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.3.2 North America Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Anti-Infectives Sales Volume
3.4.1 East Asia Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Anti-Infectives Sales Volume (2016-2021)
3.5.1 Europe Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Anti-Infectives Sales Volume (2016-2021)
3.6.1 South Asia Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Anti-Infectives Sales Volume (2016-2021)
3.7.1 Southeast Asia Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Anti-Infectives Sales Volume (2016-2021)
3.8.1 Middle East Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Anti-Infectives Sales Volume (2016-2021)
3.9.1 Africa Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Anti-Infectives Sales Volume (2016-2021)
3.10.1 Oceania Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Anti-Infectives Sales Volume (2016-2021)
3.11.1 South America Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.11.2 South America Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Anti-Infectives Sales Volume (2016-2021)
3.12.1 Rest of the World Anti-Infectives Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Anti-Infectives Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Anti-Infectives Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Anti-Infectives Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Anti-Infectives Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Anti-Infectives Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Anti-Infectives Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Anti-Infectives Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Anti-Infectives Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Anti-Infectives Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Anti-Infectives Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Anti-Infectives Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Anti-Infectives Sales Volume Market Share by Type (2016-2021)
14.2 Global Anti-Infectives Sales Revenue Market Share by Type (2016-2021)
14.3 Global Anti-Infectives Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Anti-Infectives Consumption Volume by Application (2016-2021)
15.2 Global Anti-Infectives Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Anti-Infectives Business
16.1 Astra Zeneca plc
16.1.1 Astra Zeneca plc Company Profile
16.1.2 Astra Zeneca plc Anti-Infectives Product Specification
16.1.3 Astra Zeneca plc Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Johnson & Johnson
16.2.1 Johnson & Johnson Company Profile
16.2.2 Johnson & Johnson Anti-Infectives Product Specification
16.2.3 Johnson & Johnson Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Glaxo SmithKline plc
16.3.1 Glaxo SmithKline plc Company Profile
16.3.2 Glaxo SmithKline plc Anti-Infectives Product Specification
16.3.3 Glaxo SmithKline plc Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Anti-Infectives Product Specification
16.4.3 Novartis Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Pfizer
16.5.1 Pfizer Company Profile
16.5.2 Pfizer Anti-Infectives Product Specification
16.5.3 Pfizer Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Wockhardt ltd
16.6.1 Wockhardt ltd Company Profile
16.6.2 Wockhardt ltd Anti-Infectives Product Specification
16.6.3 Wockhardt ltd Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Roche
16.7.1 Roche Company Profile
16.7.2 Roche Anti-Infectives Product Specification
16.7.3 Roche Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Sanofi
16.8.1 Sanofi Company Profile
16.8.2 Sanofi Anti-Infectives Product Specification
16.8.3 Sanofi Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Merck
16.9.1 Merck Company Profile
16.9.2 Merck Anti-Infectives Product Specification
16.9.3 Merck Anti-Infectives Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Anti-Infectives Manufacturing Cost Analysis
17.1 Anti-Infectives Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Anti-Infectives
17.4 Anti-Infectives Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Anti-Infectives Distributors List
18.3 Anti-Infectives Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Anti-Infectives (2022-2027)
20.2 Global Forecasted Revenue of Anti-Infectives (2022-2027)
20.3 Global Forecasted Price of Anti-Infectives (2016-2027)
20.4 Global Forecasted Production of Anti-Infectives by Region (2022-2027)
20.4.1 North America Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.3 Europe Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.7 Africa Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.9 South America Anti-Infectives Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Anti-Infectives Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Anti-Infectives by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Anti-Infectives by Country
21.2 East Asia Market Forecasted Consumption of Anti-Infectives by Country
21.3 Europe Market Forecasted Consumption of Anti-Infectives by Countriy
21.4 South Asia Forecasted Consumption of Anti-Infectives by Country
21.5 Southeast Asia Forecasted Consumption of Anti-Infectives by Country
21.6 Middle East Forecasted Consumption of Anti-Infectives by Country
21.7 Africa Forecasted Consumption of Anti-Infectives by Country
21.8 Oceania Forecasted Consumption of Anti-Infectives by Country
21.9 South America Forecasted Consumption of Anti-Infectives by Country
21.10 Rest of the world Forecasted Consumption of Anti-Infectives by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices